Search Results

You are looking at 101 - 110 of 438 items for :

Clear All
Full access

, Placebo-Controlled Trial of Panax Ginseng for Cancer-Related Fatigue in Patients With Advanced Cancer Yennurajalingam Sriram a MD, MS Tannir Nizar M. b MD Williams Janet L. a MPH Lu Zhanni a MS Hess Kenneth R. c PhD

Full access

Theresa L. 22 MD Dwyer Mary A. 23 MS Hughes Miranda 23 PhD 10 2013 11 11 10 10 1199 1199 1209 1209 jnccn0111199 10.6004/jnccn.2013.0142 Computer/Online-Mediated Social Support for Cancer-Related Fatigue Wagner-Johnston Nina MD

Full access

3 RN, CCM Ho Maria 23 PhD 06 2014 12 12 6 6 863 863 868 868 jnccn0120863 10.6004/jnccn.2014.0081 Survivorship: Fatigue, Version 1.2014 Denlinger Crystal S. MD Ligibel Jennifer A. MD Are Madhuri MD Baker K. Scott MD

Full access

Stacy d Subramaniam Chitra e PhD Layton Sherry f MA Grichnik Katherine g MD, MS, FASE 8 2015 13 13 8 8 1005 1005 1011 1011 0131005 10.6004/jnccn.2015.0121 Cancer-Related Fatigue, Version 2.2015 Berger Ann M. PhD, APRN

Full access

Margaret Tempero

quite a while, and travel restrictions remain in effect, which is fine, because all the big professional meetings we enjoy each spring and summer are being held virtually for the second year in a row. I do have mask fatigue, though. I don’t find

Full access

, but in the advanced setting can be very disabling and can impact quality of life (QOL) due to diarrhea, bowel obstructions, pain, weight loss, depression, and fatigue. Many of the abdominal symptoms are caused by the dense adhesions. Midgut carcinoids

Full access

within 5 years of diagnosis. Carcinoids are generally slow-growing tumors, but in the advanced setting can be very disabling and impact quality of life (QoL) due to diarrhea, bowel obstructions, pain, weight loss, depression, and fatigue. Many of the

Full access

REMS. The table below reflects a sample of drugs recently added that may be used for a supportive care indication (e.g., pain, cancer-related fatigue) in a patient with cancer. All the drugs listed require the provision of a medication guide detailing

Full access

Barry D. Bultz, Amy Waller, Jodi Cullum, Paula Jones, Johan Halland, Shannon L. Groff, Catriona Leckie, Lisa Shirt, Scott Blanchard, Harold Lau, Jacob Easaw, Konrad Fassbender and Linda E. Carlson

integrated into regular clinical practice and run by frontline clinic staff. Screening was linked with follow-up care and services, including psychosocial resources, pain and fatigue clinics, nutrition services, and palliative care, using referral guidelines

Full access

David Cella, Sarah K. Rosenbloom, Jennifer L. Beaumont, Susan E. Yount, Diane Paul, Debra Hampton, Amy P. Abernethy, Paul B. Jacobsen, Karen Syrjala and Jamie H. Von Roenn

symptoms specific to a given tumor can represent efficacy in achieving a meaningful patient outcome. Most validated measures of cancer-specific quality of life incorporate an assessment of certain prevalent symptoms, such as pain and fatigue, within a